Jean-Francois Gimonet
Plus aucun poste en cours
Profil
Jean-Francois Gimonet served as Deputy Chairman at ASTA Medica Oncology and Global Medico-Marketing Director at Baxter SAS.
He also served as Vice President-European Operations at Abraxis BioScience, Inc. from 2008 to 2011.
Gimonet holds a doctorate degree from Universite Paris Est.
Creteil Val De Marne.
Anciens postes connus de Jean-Francois Gimonet
| Sociétés | Poste | Fin |
|---|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Directeur des opérations | 14/07/2009 |
| ASTA Medica Oncology | Directeur/Membre du Conseil | - |
Baxter SAS
 Baxter SAS Medical DistributorsDistribution Services Baxter SAS distributes pharmaceutical products for intravenous therapy, renal failure and other chronic and serious diseases. The company was founded by Ralph Falk and Don Baxter in 1931 and is headquartered in Guyancourt, France. | Sales & Marketing | - |
Formation de Jean-Francois Gimonet
| Universite Paris Est Creteil Val De Marne | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Baxter SAS
Baxter SAS Medical DistributorsDistribution Services Baxter SAS distributes pharmaceutical products for intravenous therapy, renal failure and other chronic and serious diseases. The company was founded by Ralph Falk and Don Baxter in 1931 and is headquartered in Guyancourt, France. | Distribution Services |
| ASTA Medica Oncology |
